Bacterial vaginosis
| Subclass of | vaginitis, bacterial infectious disease, disease |
|---|---|
| Facet give | women's health |
| Has cause | Gardnerella vaginalis |
| Health specialty | gynaecology |
| Drug or therapy used for treatment | acetic acid, clindamycin, metronidazole |
Bacterial vaginosis (BV) be an infection of de vagina wey excessive growth of bacteria cause.[1][2] Common symptoms dey include increased vaginal discharge wey often dey smell like fish.[3] De discharge usually be white anaa gray in color.[3] Burning plus urination fi occur.[3] Itching be uncommon.[1][3] Occasionally, der fi be no symptoms.[3] Having BV approximately dey double de risk of infection by a number of sexually transmitted infections, wey dey include HIV/AIDS.[4][5] E sanso dey increase de risk of early delivery among pregnant women.[6][7]
BV be caused by an imbalance of de naturally occurring bacteria insyd de vagina.[8][9] Der be a change insyd de most common type of bacteria den a hundred to thousandfold increase insyd total numbers of bacteria present.[1] Typically, bacteria oda dan Lactobacilli cam be more common.[10] Risk factors dey include douching, new anaa multiple sex partners, antibiotics, den using an intrauterine device, among odas.[9] However, e no be considered a sexually transmitted infection den, unlike gonorrhoea den chlamydia, sexual partners no be treated.[11] Diagnosis be suspected based on de symptoms, wey e fi be verified by testing de vaginal discharge den finding a higher dan normal vaginal pH, den large numbers of bacteria.[1] BV often be confused plus a vaginal yeast infection anaa infection plus Trichomonas.[12]
Usually treatment be plus an antibiotic, such as clindamycin anaa metronidazole.[1][13] Dese medications sanso fi be used insyd de second anaa third trimesters of pregnancy.[1] De antiseptic boric acid sanso fi be effective.[14] BV often dey recur dey follow treatment.[1] Probiotics fi help prevent re-occurrence.[1][15] E be unclear if de use of probiotics anaa antibiotics dey affect pregnancy outcomes.[1][16]
BV be de most common vaginal infection insyd women of reproductive age.[9] Prevalence dey differ by countries den demographics, plus a systematic review den meta-analysis finding global prevalence insyd reproductive aged women wey dey range from 23 to 29%.[17][18] While BV-like symptoms be described for much of recorded history, de first clearly documented case occur insyd 1894.[19]
References
[edit | edit source]- 1 2 3 4 5 6 7 8 9 Donders GG, Zodzika J, Rezeberga D (April 2014). "Treatment of bacterial vaginosis: what we have and what we miss". Expert Opinion on Pharmacotherapy. 15 (5): 645–57. doi:10.1517/14656566.2014.881800. PMID 24579850. S2CID 19241611.
- ↑ Sharma H, Tal R, Clark NA, Segars JH (January 2014). "Microbiota and pelvic inflammatory disease". Seminars in Reproductive Medicine. 32 (1): 43–9. doi:10.1055/s-0033-1361822. PMC 4148456. PMID 24390920.
- 1 2 3 4 5 "What are the symptoms of bacterial vaginosis?". National Institute of Child Health and Human Development. 2013-05-21. Archived from the original on 2 April 2015. Retrieved 3 March 2015.
- ↑ Kenyon C, Colebunders R, Crucitti T (December 2013). "The global epidemiology of bacterial vaginosis: a systematic review". American Journal of Obstetrics and Gynecology. 209 (6): 505–23. doi:10.1016/j.ajog.2013.05.006. PMID 23659989.
- ↑ Bradshaw CS, Brotman RM (July 2015). "Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure". BMC Infectious Diseases. 15 292. doi:10.1186/s12879-015-1027-4. PMC 4518586. PMID 26219949.
- ↑ Queena JT, Spong CY, Lockwood CJ, eds. (2012). Queenan's management of high-risk pregnancy: an evidence-based approach (6th ed.). Chichester, West Sussex: Willey-Blackwell. p. 262. ISBN 978-0-470-65576-4.
- ↑ "What are the treatments for bacterial vaginosis (BV)?". National Institute of Child Health and Human Development. 2013-07-15. Archived from the original on 2 April 2015. Retrieved 4 March 2015.
- ↑ Bennett J (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4557-4801-3.
- 1 2 3 "Bacterial Vaginosis (BV): Condition Information". National Institute of Child Health and Human Development. 2013-05-21. Archived from the original on 2 April 2015. Retrieved 3 March 2015.
- ↑ Nardis C, Mosca L, Mastromarino P (September–October 2013). "Vaginal microbiota and viral sexually transmitted diseases". Annali di Igiene. 25 (5): 443–56. doi:10.7416/ai.2013.1946. PMID 24048183.
- ↑ "Bacterial Vaginosis – CDC Fact Sheet". Centers for Disease Control and Prevention. 11 March 2014. Archived from the original on 28 February 2015. Retrieved 2 March 2015.
- ↑ Mashburn J (2006). "Etiology, diagnosis, and management of vaginitis". Journal of Midwifery & Women's Health. 51 (6): 423–30. doi:10.1016/j.jmwh.2006.07.005. PMID 17081932.
- ↑ Faught BM, Reyes S (September 2019). "Characterization and Treatment of Recurrent Bacterial Vaginosis". J Women's Health (Larchmt). 28 (9): 1218–1226. doi:10.1089/jwh.2018.7383. PMID 31403349.
- ↑ Lærkeholm Müller, Matilde; Damsted Petersen, Christina; Saunte, Ditte Marie L. (2024). "Boric Acid for the Treatment of Vaginitis: New Possibilities Using an Old Anti-Infective Agent: A Systematic Review". Dermatologic Therapy. 2024 (1) 2807070. Wiley. doi:10.1155/2024/2807070. ISSN 1396-0296.
- ↑ Chieng WK, Abdul Jalal MI, Bedi JS, Zainuddin AA, Mokhtar MH, Abu MA, Chew KT, Nur Azurah AG (2022). "Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials". Front Nutr. 9 938838. doi:10.3389/fnut.2022.938838. PMC 9530327. PMID 36204368.
- ↑ Othman M, Neilson JP, Alfirevic Z (January 2007). "Probiotics for preventing preterm labour". The Cochrane Database of Systematic Reviews. 2012 (1) CD005941. doi:10.1002/14651858.CD005941.pub2. PMC 9006117. PMID 17253567.
- ↑ "Bacterial vaginosis". www.who.int (in English). Archived from the original on 11 November 2023. Retrieved 2025-07-19.
- ↑ Peebles, Kathryn; Velloza, Jennifer; Balkus, Jennifer E.; McClelland, R. Scott; Barnabas, Ruanne V. (May 2019). "High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis". Sexually Transmitted Diseases (in American English). 46 (5): 304–311. doi:10.1097/OLQ.0000000000000972. ISSN 0148-5717. PMID 30624309. Archived from the original on 15 July 2025. Retrieved 19 July 2025.
- ↑ Borchardt KA (1997). Sexually transmitted diseases: epidemiology, pathology, diagnosis, and treatment. Boca Raton [u.a.]: CRC Press. p. 4. ISBN 978-0-8493-9476-8. Archived from the original on 10 September 2017.
External links
[edit | edit source]- WHO fact sheet on bacterial vaginosis Archived 11 November 2023 at the Wayback Machine